LATE-BREAKING CLINICAL TRIALS

Monday, November 3, 2025

10:40am - 12:02pm PT

Moderator(s)

Eric Secemsky, MD, MSc

Associate Professor of Medicine
Beth Israel Deaconess Medical Center/Harvard Medical School
Interventional Cardiology
Boston, Massachusetts, United States

Disclosure(s): Abbott, Asahi, BD, Boston Scientific, Conavi, Cook, Cordis, Endovascular Engineering, Evident Vascular, Gore, InfraRedx, Medtronic, Penumbra, Philips, RapidAI, Rampart IC, R3, Regeneron, Shockwave, Siemens, SoniVie, Teleflex, Terumo, Thrombolex, Vent: Advisory Board; Consultant

Panel(s)

Herbert Aronow, MD, MPH

Medical Director, Heart & Vascular Services
Henry Ford Health
Interventional Cardiology
Detroit, Michigan, United States

Disclosure information pending.
Misty Humphries, MD

Professor of Surgery, Interim Chief of Vascular Surgery
UC Davis Health
Vascular Surgery
Sacramento, California, United States

Disclosure(s): Boston Scientific: Advisory Board; Consultant
InspireMD: Grants/Research Support Recipient
Shockwave: Consultant
Michael Jolly, MD

Interventional Cardiologist
OhioHealth Riverside Methodist Hospital
Interventional Cardiology
Columbus, Ohio, United States

Disclosure(s): Contego: Consultant
Inari Medical: Consultant
Medtronic: Consultant
Parag Patel, MD, MS

Professor
Medical College of Wisconsin
Interventional Radiology
Milwaukee, Wisconsin, United States

Disclosure(s): BD (formerly Bard): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Boston Scientific: Advisory Board; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Cook Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Medtronic: Advisory Board
Penumbra: Advisory Board; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Philips: Consultant
Constantino Pena, MD

Interventional Radiology Section Lead
Miami Cardiac & Vascular Institute
Interventional Radiology
Miami, Florida, United States

Disclosure(s): Asahi: Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Avanos: Advisory Board
BD (formerly Bard): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Cagent Vascular: Stockholder - Privately-held company
Cook Medical: Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Cordis: Consultant
FastWave Medical: Stockholder - Privately-held company
Medtronic: Consultant
Penumbra: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Philips: Consultant
Shockwave: Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Terumo: Consultant
TS

Tamara Syrek Jensen

Disclosure information pending.
Ido Weinberg, MD

Disclosure(s): Nova Pulse: Consultant
Penumbra: Consultant

Presentations:

10:40am - 10:48am PT

Integrated Embolic Protection in TCAR: 30-Day Results From the PERFORMANCE III Trial
Speaker: Sean P. Lyden, MD – Cleveland Clinic
10:48am - 10:52am PT

Panel Discussion
10:52am - 11:02am PT

Prolonged Efficacy and Safety of a Drug-Eluting Resorbable Scaffold in CLTI: 3-Year Outcomes and Subgroup Analyses From the LIFE-BTK Trial
Speaker: Sahil A. Parikh, MD – New York Presbyterian/Columbia University Irving Medical Center
11:02am - 11:06am PT

Panel Discussion
11:06am - 11:16am PT

One-Year Outcomes From the Disrupt PAD BTK II Study: Treatment of Patients With Calcified Below-the-Knee Lesions With a Peripheral Intravascular Lithotripsy System
Speaker: Ehrin Armstrong, MD – Swedish Medical Center
11:16am - 11:20am PT

Panel Discussion
11:20am - 11:30am PT

Novel Thrombectomy System for Acute Intermediate-Risk Pulmonary Embolism: Full Results From the Pivotal ENGULF Trial
Speaker: Andrew Klein, MD – Piedmont Healthcare
11:30am - 11:34am PT

Panel Discussion
11:34am - 11:44am PT

STRIKE-PE: 1-Year Functional Outcomes and Quality of Life in Pulmonary Embolism Patients Treated With Computer-Assisted Vacuum Thrombectomy Using the 16F Catheter System
Speaker: John Moriarty, MD – UCLA
11:44am - 11:48am PT

Panel Discussion
11:48am - 11:58am PT

Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation vs Anticoagulation Alone for Acute Intermediate-High-Risk PE: Primary Outcome, Functional Endpoints, and Core Lab Findings From STORM-PE
Speaker: Rachel Rosovsky, MD, MPH – Massachusetts General Hospital and Harvard Medical School
11:58am - 12:02pm PT

Panel Discussion